NDAQ240517C52500
- 7.73
- 0.000.00%
Nasdaq Newsroom
🎬 Join the Excitement: Moomoo's Nasdaq Tour Recap! 🎉 Check out and Win Points!
We're thrilled to announce that we've teamed up with Nasdaq and just host an unforgettable event at the iconic Nasdaq MarketSite in Times Square on 29th April. 🎉
Market Chatter: EU Antitrust Regulators Seek Feedback on EEX-Nasdaq Deal
The European Commission is seeking feedback on the European Energy Exchange's acquisition of Nasdaq's (NDAQ) European power trading and clearing business, Reuters reported Wednesday, citing a person w
IMTE Announces Receipt of Deficiency Letter From Nasdaq
NEW YORK and SYDNEY, May 22, 2024 /PRNewswire/ -- Integrated Media Technology Limited (NASDAQ: IMTE) ("IMTE" or the "Company"), an Australia company that is engaged in the businesses of the trading i
IPO Edge Fireside Chats at Nasdaq on June 11
Veon Says Working on Plan to Regain Compliance for Nasdaq Listing
Veon (VEON.AS) is working on a plan to regain listing rules compliance on Nasdaq after receiving a letter from the bourse operator due to its failure to submit its 2023 annual report on time. The Dutc
Sector Update: Financial Stocks Higher Late Afternoon
Financial stocks advanced in late Tuesday afternoon trading, with the NYSE Financial Index rising 0.2% and the Financial Select Sector SPDR Fund (XLF) adding 0.6%. The Philadelphia Housing Index fell
Market Chatter: SEC Asks Nasdaq, CBOE, NYSE to Adjust Filings for Ether ETF Listing
Nasdaq (NDAQ), Cboe Global Markets (CBOE) and the New York Stock Exchange were asked by the US Securities and Exchange Commission to fine-tune listing applications for ether exchange-traded-funds, Reu
Sonder Gets Nasdaq Warning Over Delayed Filing of Quarterly Report
Sonder (SOND) said late Friday it has received a notification from Nasdaq for failing to timely file its quarterly report on Form 10-Q for the quarter ended March 31 and annual report on Form 10-K for
Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. From The Nasdaq Stock Market
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.'s securities were suspended on March 18,
Press Release: Nasdaq Announces 2024 Annual Meeting of Shareholders
Nasdaq Announces 2024 Annual Meeting of Shareholders NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) has scheduled its 2024 Annual Meeting of Shareholders for June 11, 2024, at
Nasdaq Is Maintained at Buy by Argus Research
Nasdaq Is Maintained at Buy by Argus Research
Nasdaq Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 9.63% Argus Research $64 → $66 Maintains Buy 05/08/2024 6.31% Rosenblatt $76 → $64 Downgrades B
Argus Adjusts Price Target on Nasdaq to $66 From $64
Nasdaq (NDAQ) has an average outperform rating and a price target range of $50 to $80, according to analysts polled by Capital IQ. Price: 61.35, Change: +0.73, Percent Change: +1.21
Nasdaq Announces 2024 Annual Meeting of Shareholders
PDF Version NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) has scheduled its 2024 Annual Meeting of Shareholders for June 11, 2024, at 8:00 AM ET. The virtual meeting we
Full Video Coverage: Three CFOs on IPOs Panel From IPO Edge Bootcamp at Nasdaq
Full Video Coverage: Investor Engagement in Private Vs. Public Markets Panel From IPO Edge Bootcamp at Nasdaq
Intel Rises on Report of $11 Billion Apollo Investment in New Chip Plant
By Steve Gelsi Apollo is front-runner on deal after it outshines KKR and Stonepeak, the WSJ report says Intel Corp's stock rose 2.5% on Monday after The Wall Street Journal reported it was in talks
Sector Update: Financial
Financial stocks were easing in Monday afternoon trading, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) both off 0.2% recently. The Philadelphia Housing Index was shedd
Update: Market Chatter: Nasdaq Considering Sale of Solovis Business
(Updates with additional details in the second and third paragraphs, Nasdaq declines to comment in the fourth paragraph.) Nasdaq (NDAQ) is considering a sale of its Solovis business as part of an effo
Nasdaq Weighs Sale of Solovis Unit in Wake of Adenza Acquisition - Report